The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Tecentriq
Australian Public Assessment Report
Device/Product Name
Tecentriq
Active ingredients
Atezolizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04838-1-4
Submission Type
Provisional to full registration
Decision
Sponsor withdrew on 21 March 2023